Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in RELAY THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 210,468 shares of RLAY (RELAY THERAPEUTICS INC), worth $2.1M as of 2026-Q1. The position was increased (+0.3% shares). RLAY represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$2.1M
Current Shares
210,468
Total Value Change
+$727,245
Total Shares Change
+819
Other major holders of RLAY: BNP PARIBAS FINANCIAL MARKETS, SB INVESTMENT ADVISERS (UK) LTD
Increased |
| 210,468 |
+0.3% |
| $2.1M |
| 0.0% |
| $9.85 |
26 |
| 2025-Q4 | Increased | 209,848 | +3.8% | $1.8M | 0.0% | $8.35 | 27 |
| 2025-Q3 | Decreased | 202,244 | -50.5% | $1.1M | 0.0% | $5.19 | 0 |
| 2025-Q2 | Increased | 408,902 | +35.6% | $1.4M | 0.0% | $3.30 | 33 |
| 2025-Q1 | Increased | 301,550 | +29.6% | $790,060 | 0.0% | $2.72 | 31 |
| 2024-Q4 | Increased | 232,582 | +4.2% | $958,238 | 0.0% | $4.18 | 26 |
| 2024-Q3 | Increased | 223,289 | +6.5% | $1.6M | 0.0% | $7.46 | 27 |
| 2024-Q2 | Decreased | 209,649 | -62.4% | $1.4M | 0.0% | $6.52 | 0 |